Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Vera Bradley, Inc. (VRA)
|
Add to portfolio |
|
|
Price: |
$8.59
| | Metrics |
OS: |
30.9
|
M
| |
-26
|
% ROE
|
Market cap: |
$265
|
M
| |
-19
|
% ROIC
|
Net cash:
|
$25.3
|
M
| |
$0.82
|
per share
|
EV:
|
$240
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($50.9)
|
M
| |
|
|
EBIT
|
($63.7)
|
M
| |
|
|
EPS |
($2.08)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jan-28-23 | Jan-29-22 | Jan-30-21 | Feb-01-20 | Feb-02-19 | Feb-03-18 | Jan-28-17 | Jan-30-16 |
Revenues | 500.0 | 540.5 | 468.3 | 495.2 | 416.1 | 454.6 | 485.9 | 502.6 |
Revenue growth | -7.5% | 15.4% | -5.4% | 19.0% | -8.5% | -6.4% | -3.3% | -1.3% |
Cost of goods sold | 261.0 | 252.5 | 202.8 | 223.4 | 177.5 | 200.6 | 209.9 | 221.4 |
Gross profit | 238.9 | 287.9 | 265.5 | 271.8 | 238.6 | 254.0 | 276.0 | 281.2 |
Gross margin | 47.8% | 53.3% | 56.7% | 54.9% | 57.3% | 55.9% | 56.8% | 55.9% |
Selling, general and administrative | 265.0 | 262.0 | 252.6 | 253.4 | 212.0 | 239.8 | 249.2 | 236.8 |
EBITA | -91.6 | 30.0 | 22.1 | 24.8 | 27.1 | 31.7 | 28.2 | 46.7 |
EBITA margin | -18.3% | 5.5% | 4.7% | 5.0% | 6.5% | 7.0% | 5.8% | 9.3% |
Amortization of intangibles | 3.3 | 3.1 | 9.0 | 5.4 | | | | |
EBIT | -94.9 | 26.9 | 13.1 | 19.5 | 27.1 | 31.7 | 28.2 | 46.7 |
EBIT margin | -19.0% | 5.0% | 2.8% | 3.9% | 6.5% | 7.0% | 5.8% | 9.3% |
Pre-tax income | -95.0 | 26.6 | 11.9 | 20.6 | 28.2 | 15.4 | 28.0 | 46.5 |
Income taxes | -15.6 | 6.4 | 1.2 | 5.3 | 7.5 | 8.4 | 8.3 | 18.9 |
Tax rate | 16.5% | 24.1% | 9.9% | 25.9% | 26.5% | 54.4% | 29.5% | 40.7% |
Net income | -59.7 | 20.2 | 10.7 | 15.2 | 20.8 | 7.0 | 19.8 | 27.6 |
Net margin | -11.9% | 3.7% | 2.3% | 3.1% | 5.0% | 1.5% | 4.1% | 5.5% |
|
Diluted EPS | ($1.90) | $0.59 | $0.32 | $0.44 | $0.59 | $0.19 | $0.53 | $0.71 |
Shares outstanding (diluted) | 31.5 | 34.4 | 33.9 | 34.3 | 35.5 | 36.0 | 37.0 | 38.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|